Most telehealth weight loss companies want you to think they are roughly the same. They are not. Pricing spreads are wild, pharmacy transparency ranges from solid to basically nonexistent, and the FDA’s 2026 warning letters to over 30 compounding telehealth firms made it clear that “compounded GLP-1” is not a uniform product. The five picks below reflect what actually keeps coming up when people compare these services honestly, whether in forums, Reddit threads, or word-of-mouth among patients who have tried more than one.
1. HealthRX
Compounded tirzepatide starting at $149 a month makes HealthRX one of the most competitive cash-pay prices in this category. That alone attracts attention, but the more interesting detail is where the medication comes from. Manifest Pharmacy in Greer, South Carolina is a 503A compounding pharmacy operating under USP-797 standards, with lot-level tracking from production to your door. That is an unusually specific piece of information for a telehealth brand to publish, and it matters in a space where “compounded in a certified pharmacy” often means nothing traceable.
Free overnight shipping to all 50 states, LegitScript certification (cert 50087439), and a physician review window around 24 hours round out the practical picture. The SURMOUNT-1 trial data HealthRX references, roughly 21% average body weight reduction over 72 weeks, comes from the clinical literature, not its own patients. Worth keeping in mind. Still, for straight cash-pay value and supply chain visibility, this one is hard to beat right now.
2. Mochi Health
Mochi puts board-certified obesity-medicine physicians on the other side of your consultation, not just general practitioners. That distinction matters for dosing decisions and monitoring. Compounded semaglutide runs about $99 a month, compounded tirzepatide around $199. The monitoring cadence is heavier than many competitors, which some patients appreciate and others find excessive. If you want a provider who will actually adjust your protocol rather than just renew it, Mochi is frequently the name that comes up.
3. FormBlends
FormBlends earns a spot here for a specific reason: it publishes per-product purity testing. HPLC purity percentages, mass spec identity confirmation, endotoxin and sterility results are listed by product, not just implied by a pharmacy certification badge. For patients who want to see the actual numbers before injecting anything, that is meaningful.
Pricing is higher. Semaglutide runs around $299, tirzepatide around $349, both cash-pay per vial. Shipping covers 47 states, not 50. It ranks below HealthRX here purely on price-to-access math, but it is the pick if published test data or access to a broader peptide catalog (recovery, longevity, and cognitive compounds handled under the same clinician model) is a priority for you. Very few GLP-1-only telehealth brands offer that range.
4. Ro Body
Ro has a prior-authorization team that will work to get branded medications covered through your insurance. That is genuinely useful and not something every telehealth platform offers in any real way. The membership structure starts at about $39 for the first month, then $74 to $149 monthly, with medication costs billed separately. Ro also connects to branded products like Zepbound if compounded is not your preference. The platform is larger and more structured than most on this list, which is either a feature or friction depending on what you want from the experience.
5. Hims & Hers
After the March 2026 Novo Nordisk settlement, Hims and Hers shifted away from compounded semaglutide and moved to branded medications. Injectable Wegovy is listed at roughly $299 a month, oral options around $249, and Zepbound at approximately $399. With insurance and a savings card, out-of-pocket cost can drop dramatically, sometimes to near zero. It is a reasonable pick for someone who specifically wants branded GLP-1 medications through a slick app-based interface and has insurance they want to put to work.
A note before you act on any of this: compounded medications, tirzepatide included, are not FDA-approved products. Clinical trial results cited by any of these providers come from studies on the branded drugs, not the compounded versions. Talk to a physician you trust before starting, especially if you have any cardiac, gastrointestinal, or thyroid history.
Common Questions
Does it matter which compounding pharmacy a telehealth clinic uses?
Yes, significantly. A 503A pharmacy like Manifest Pharmacy operates under USP-797 sterility standards with lot-level tracking. Many telehealth brands name no pharmacy at all. The difference between a traceable, standards-compliant compounder and an unnamed one is not cosmetic. It affects what you actually receive and your ability to investigate any quality issue.
Is compounded tirzepatide the same drug as Zepbound?
No. Compounded tirzepatide contains the same active molecule but is not FDA-approved and is not manufactured by Eli Lilly. Efficacy data from the SURMOUNT-1 trial applies to Lilly’s branded product. Whether compounded versions perform identically has not been established in peer-reviewed clinical trials, and no telehealth brand has conducted that comparison independently.
Which of these clinics is worth paying more for if you want lab-verified purity?
FormBlends publishes HPLC purity percentages, mass spec identity confirmation, and endotoxin and sterility results per product. That is a higher level of documentation than any other clinic on this list provides. You pay for it: tirzepatide runs about $349 per vial versus $149 a month at HealthRX. Whether that premium matters to you depends on your risk tolerance.
Can Ro Body actually get Zepbound covered by insurance, or is that mostly marketing?
Ro has a dedicated prior-authorization team, which is a real operational resource, not just a checkbox on a features page. Whether it succeeds depends entirely on your specific plan. No telehealth platform can guarantee insurance approval. Ro’s structure makes it a reasonable starting point if insurance coverage is your main goal, but go in with realistic expectations.
After the 2026 FDA warning letters, is it still legal to buy compounded tirzepatide?
Compounded tirzepatide from a licensed 503A pharmacy prescribed by a licensed physician remains legal as of the time this article was written. The FDA warning letters targeted specific firms for labeling violations and other compliance failures, not the practice of compounding tirzepatide outright. Regulatory status can shift. Checking the FDA’s current shortage and enforcement pages before you subscribe is a reasonable step.
Sources
- FDA warning letters to telehealth and compounding firms, early 2026 (FDA.gov public records)
- SURMOUNT-1 trial, *New England Journal of Medicine*, 2022 (tirzepatide efficacy data)
- STEP 1 trial, *New England Journal of Medicine*, 2021 (semaglutide efficacy data)
- LegitScript certification database (legitscript.com, public lookup)
- Novo Nordisk settlement reporting, March 9 2026, *Reuters* and *STAT News*
- Lilly orforglipron / LillyDirect pricing, *Forbes Health* and Lilly press release, April 2026
